multi-site trial
-
adverse events, depression, double-blind trial, Editor Eimear Foley, generalisability, Germany, hallucinogens, Hamilton Depression scale, JAMA Psychiatry, major depressive disorder, medicines, multi-site trial, placebo effects, psilocybin, psychedelics, psychopharmacology, psychotherapies, psychotherapy, randomised controlled trial, remission, response, treatment-resistant depression, unblindingPsilocybin-assisted therapy for difficult-to-treat depression: underwhelming, but still vital?
Psychedelics were once, not so long ago, held up by select vocal…
